<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Evofem_Biosciences%2C_Inc.</id>
	<title>Evofem Biosciences, Inc. - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Evofem_Biosciences%2C_Inc."/>
	<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Evofem_Biosciences,_Inc.&amp;action=history"/>
	<updated>2026-04-16T19:45:36Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.5</generator>
	<entry>
		<id>https://stockhub.co/index.php?title=Evofem_Biosciences,_Inc.&amp;diff=69151&amp;oldid=prev</id>
		<title>95.149.241.133: Created page with &quot;== Summary&lt;ref&gt;Source: Yahoo Finance.&lt;/ref&gt; ==  Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women&#039;s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisser...&quot;</title>
		<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Evofem_Biosciences,_Inc.&amp;diff=69151&amp;oldid=prev"/>
		<updated>2022-09-23T08:23:37Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==  Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women&amp;#039;s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisser...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women&amp;#039;s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.&lt;br /&gt;
&lt;br /&gt;
== References and notes == &lt;br /&gt;
[[Category:Thesis]]&lt;br /&gt;
__INDEX__&lt;/div&gt;</summary>
		<author><name>95.149.241.133</name></author>
	</entry>
</feed>